Device

Part:BBa_K4375018

Designed by: Zska Csorba   Group: iGEM22_ELTE   (2022-09-29)


MiniNano for bacterial surface display

This construction consists of 4 described parts. These are: Codon optimalised INPNC for Surface Display (BBa_K4375007), flexible GS-linker (BBa_K4375010), miRFP670 nano (BBa_K4375008), J23101* (BBa_K4375003). They allow the bacterium to be expelled to the tumor surface, thus allowing its visualisation and colonisation on the tumour surface.



Usage and Biology

The MiniNano is a compact construct meant for extracellular protein (like tumor-specific receptor, antigen, etc.) detection via fluorescence. This protein has 3 domains. (1) INPNC surface display module (INPNC codes for N- and C- terminal domain of Ice Nucleation Protein (INP) from Pseudomonas syringe, and it is used for displaying proteins on bacteria's outer membrane (BBa_K4375007). It is linked to (by a flexible GS-linker, BBa_K4375010) (2) a small, near-infrared emitting fluorescent protein, miRFP670 nano (BBa_K4375008), which is connected to an anti-EGFR specific Nanobody, 7D12, via llama-derived IgA hinge region linker (BBa_K4375011). Moreover, it contains a Myc epitope tag, so the specific interaction can be detected with labelled antibodies. This complex detection device is expressed under the constitutive promoter J23101* (BBa_K4375003) The Nanobody in the construct can be easily swapped with other protein domains, as its sequence is framed by BamHI and SphI restriction sites

Figure 1: MiniNano composite scheme.


Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 1055
    Illegal PstI site found at 1313
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 7
    Illegal NheI site found at 29
    Illegal PstI site found at 1055
    Illegal PstI site found at 1313
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 1055
    Illegal PstI site found at 1313
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 1055
    Illegal PstI site found at 1313
    Illegal NgoMIV site found at 118
    Illegal NgoMIV site found at 451
    Illegal AgeI site found at 869
    Illegal AgeI site found at 1523
    Illegal AgeI site found at 1655
  • 1000
    COMPATIBLE WITH RFC[1000]

References

Wu, P.-H.; Giridhar, R.; Wu, W.-T. Surface Display of Transglucosidase onEscherichia Coli by Using the Ice Nucleation Protein ofXanthomonas Campestris and Its Application in Glucosylation of Hydroquinone. Biotechnology and Bioengineering 2006, 95 (6), 1138–1147. https://doi.org/10.1002/bit.21076.

https://2012.igem.org/Team:Penn/Team

„Myc-tag: An epitope tag for protein characterization, protein interaction analysis, and purification.” https://www.ptglab.com/news/blog/myc-tag-an-epitope-tag-for-protein-characterization-protein-interaction-analysis-and-purification/

Li, D.; Ren, J.; Ji, F.; Peng, Q.; Teng, H.; Jia, L. Peptide Linker Affecting the Activity Retention Rate of VHH in Immunosorbents. Biomolecules 2020, 10 (12), 1610. https://doi.org/10.3390/biom10121610

Karl R. Schmitz, Atrish Bagchi, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Kathryn M. Ferguson, Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains, Structure, Volume 21, Issue 7, 2013, Pages 1214-1224, ISSN 0969-2126, https://doi.org/10.1016/j.str.2013.05.008.

Lwin, T. M.; Turner, M. A.; Nishino, H.; Amirfakhri, S.; Hernot, S.; Hoffman, R. M.; Bouvet, M. Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer. Biomolecules 2022, 12 (5), 711. https://doi.org/10.3390/biom12050711.

De Meyer, T.; Muyldermans, S.; Depicker, A. Nanobody-Based Products as Research and Diagnostic Tools. Trends in Biotechnology 2014, 32 (5), 263–270. https://doi.org/10.1016/j.tibtech.2014.03.001.

Turner, M. A.; Lwin, T. M.; Amirfakhri, S.; Nishino, H.; Hoffman, R. M.; Yazaki, P. J.; Bouvet, M. The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review. Biomolecules 2021, 11 (12), 1819. https://doi.org/10.3390/biom11121819.

Lee, J. H.; Lee, S.-W. The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches. Gastroenterology Research and Practice 2017, 2017, 1–11. https://doi.org/10.1155/2017/7521987.

Grunnet, M.; Sorensen, J. B. Carcinoembryonic Antigen (CEA) as Tumor Marker in Lung Cancer. Lung Cancer 2012, 76 (2), 138–143. https://doi.org/10.1016/j.lungcan.2011.11.012.

Boon L., Yutong Y.; Reprogramming Synthetic Cells for Targeted Cancer Therapy 2022; 11 (3), 1349-1360 DOI: 10.1021/acssynbio.1c00631

Oliinyk, O. S.; Shemetov, A. A.; Pletnev, S.; Shcherbakova, D. M.; Verkhusha, V. V. Smallest Near-Infrared Fluorescent Protein Evolved from Cyanobacteriochrome as Versatile Tag for Spectral Multiplexing. Nature Communications 2019, 10 (1). https://doi.org/10.1038/s41467-018-08050-8.

Oliinyk, O.; Chernov, K.; Verkhusha, V. Bacterial Phytochromes, Cyanobacteriochromes and Allophycocyanins as a Source of Near-Infrared Fluorescent Probes. International Journal of Molecular Sciences 2017, 18 (8), 1691. https://doi.org/10.3390/ijms18081691.



[edit]
Categories
Parameters
None